MDT
Medtronic plc
- PER (TTM)
- 21.27
- PER (Forward)
- 12.57
- EPS (TTM)
- -
- EPS (Forward)
- -
- PBR
- 2.00
- 시가총액
- 97.77B
- 배당수익률
- 373.00%
- 베타
- 0.63
- 1개월 수익률
- -13.38%
- 3개월 수익률
- -25.39%
- 6개월 수익률
- -14.45%
- 1년 수익률
- -5.52%
- 2년 수익률
- -
- 5일 평균거래량
- 10428780
- 60일 평균거래량
- 8803200
- 1년 평균거래량
- 7771712
- 5d/60d 거래량 비율
- 1.18×
- 60d/1y 거래량 비율
- 1.13×
- 변동성(60일, 연환산)
- 21.25%
- BB 스퀴즈 스코어
- 1.93
- SMA50 비율
- 0.88
- SMA200 비율
- 0.82
- RSI (14)
- 26
- 20일 수렴도
- 0.04
- 52주 최고
- 103.73
- 52주 최저
- 76.15
- 고점 대비
- -26.59%
- 저점 대비
- 0.00%
펀더멘털 갱신: 2026-05-10T10:01:28+00:00 · 시세 갱신: 2026-05-10T06:51:00+00:00
회사 정보
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems and sensors, and InPen, a smart insulin pen. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.